The takeover also means that a related $11 billion transaction in which Novo Holdings' subsidiary Novo Nordisk takes control of three of Catalent’s fill-and-finish facilities in Italy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback